prostate cancer

Open Access
Retzius-sparing Retroperitoneal Laparoscopic Radical Prostatectomy (RSR-LRP): A Novel Technique With Favorable Functional and Oncological Outcomes – A Single-surgeon Experience of 186 Consecutive Cases
PAULIUS BOSAS and GINTARAS ZALESKIS

In Vivo May 2026, 40 (3) 1545-1551; DOI: https://doi.org/10.21873/invivo.14304
Open Access
Does Irradiation of Pelvic Lymph Nodes Have an Impact on the Bladder Filling Status in Patients With High-risk Prostate Cancer?
DIRK RADES, LAURA DOEHRING, JAN-DIRK KÜTER, CHARLOTTE KRISTIANSEN, CHRISTINE VESTERGÅRD-MADSEN, CHRISTIAN F. SCHULZ and STEFAN JANSSEN

In Vivo May 2026, 40 (3) 1733-1737; DOI: https://doi.org/10.21873/invivo.14324
Open Access
Urinary Amino Acid Profiling as a Non-invasive Diagnostic and Risk Stratification Tool in Prostate Cancer
TEREZA ZDOBINSKA, HANA LUKSANOVA, KATERINA DUSKOVA, ONDREJ PRIMAN, MATVEI SLAVENKO, MARKO BABJUK and STEPAN VESELY

In Vivo March 2026, 40 (2) 1080-1089; DOI: https://doi.org/10.21873/invivo.14262
Open Access
Cost-Effectiveness of PSMA PET/CT as Single Procedure for Diagnosis and Staging High-Grade Prostate Cancer: A Single Center Experience
PIETRO PEPE, LUDOVICA PEPE, GABRIELE PEPE and ROSARIO PRIVITERA

In Vivo March 2026, 40 (2) 963-969; DOI: https://doi.org/10.21873/invivo.14252
Open Access
FOXA1 Alterations in Prostate Cancer: Expression, Mutation Classes, and Copy Number Changes
STEVEN LEHRER and PETER RHEINSTEIN

In Vivo January 2026, 40 (1) 341-348; DOI: https://doi.org/10.21873/invivo.14197
Open Access
Impact of Cyclin-dependent Kinase Inhibitor 1A Genotypes on Prostate Cancer Susceptibility Prediction
CHENG-HSI LIAO, DA-TIAN BAU, BO-REN WANG, SHU-YU CHANG, TE-CHUN HSIA, HSU-TUNG LEE, JAW-CHYUN CHEN, WEN-CHIN HUANG, CHIA-WEN TSAI, YUN-CHI WANG, HOU-YU SHIH and WEN-SHIN CHANG

In Vivo November 2025, 39 (6) 3184-3194; DOI: https://doi.org/10.21873/invivo.14118
Open Access
Urinary Metabolites as Biomarkers of Early Radiation Cystitis in Patients With Prostate Cancer Undergoing Radiotherapy
SACHIKA SHIRAISHI, MASAHIRO SUGIMOTO and KOICHI TOKUUYE

In Vivo July 2025, 39 (4) 2091-2100; DOI: https://doi.org/10.21873/invivo.14004
Open Access
Potential Common Molecular Mechanisms Between Periodontitis and Prostate Cancer: A Network Analysis of Differentially Expressed miRNAs
AYLIN KANLI, DENİZ SUNNETCI-AKKOYUNLU, NURHAN KULCU-SARIKAYA, CANSU UGURTAŞ, GURLER AKPINAR and MURAT KASAP

In Vivo March 2025, 39 (2) 795-809; DOI: https://doi.org/10.21873/invivo.13863
Open Access
Claudin 18.2 Is Not a Promising Biomarker for Targeted Immunotherapy in Prostatic Cancers
JINA BAEK, YOUNG RAN SHIM and MI-JIN GU

In Vivo March 2025, 39 (2) 819-823; DOI: https://doi.org/10.21873/invivo.13884
Open Access
Genetic Variations in TP53, RB1, and PTEN in a Selected Sample of Slovak Patients With Metastatic Castration-resistant Prostate Cancer
KLAUDIA HIVES HOLECKOVA, MARK HIVES, MARIAN GRENDAR, HENRIETA BLAHUSIAK DROBKOVA and JAN KLIMENT

In Vivo November 2024, 38 (6) 2610-2616; DOI: https://doi.org/10.21873/invivo.13737

Main menu

User menu

Search

prostate cancer

Pages